Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Treatment burden and treatment fatigue as barriers to health2015 · 182 citations
2. 2Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe2017 · 670 citations
3. 3The Impact of Obesity on the Cardiovascular System2018 · 500 citations
4. 4The relationship between anthropometric indexes of adiposity and vascular function in the FATE cohort2013 · 26 citations
5. 5Obesity and cardiovascular diseases2017 · 214 citations